Navigation Links
BioNano Genomics Appoints Dr. Fahim Amini As Vice President Commercial Operations EMEA
Date:5/31/2013

SAN DIEGO, May 31, 2013 /PRNewswire/ -- BioNano Genomics, the developer of the Irys™ System for genome mapping, announced today the appointment of Fahim Amini , Ph.D. as vice president, Commercial Operations EMEA. Dr. Amini will further expand BioNano's commercial reach for the Irys System, making it possible for researchers and clinicians in Europe, Middle East and Africa to access BioNano's recently launched Irys platform.

"As we prepare to expand access to the Irys System globally into Europe and beyond, we are looking forward to meeting the needs of researchers and clinicians who require deeper insights into genome variations," said Todd Dickinson , Ph.D., vice president, Global Commercial Operations. "Fahim's addition to the team at BioNano Genomics is a key component of our commercial roll-out in Europe. Fahim has a proven track record in supporting labs in Europe, big and small, in the successful adoption of new platforms for genome analysis."

"This is an exciting time in genomics research, especially with a commercial system that will propel the field of genomics, with all its tremendous advances in the recent years, to the next level," said Dr. Amini.  "It is widely known that detecting structural variation and penetrating difficult repetitive regions with today's short and medium-read technologies has been challenging.  By preserving the native genomic structure, the Irys System allows new insights to be gained through direct visualization of genome structure, enabling the detection of structural variation, significantly improving genome assemblies, phasing haplotypes, and many other applications yet to be developed. I am eager to help researchers and clinicians throughout Europe, Middle East and Africa access BioNano's breakthrough genome mapping solution to drive new discoveries."

Dr. Amini was most recently director of EMEA at Complete Genomics, where he was responsible for sustainable growth of CGI revenue and support structure. Before Complete Genomics, he held several commercial roles of increasing scope and responsibility at Illumina, and prior to that, at Affymetrix. He received his Ph.D. in biological sciences and his BSc with honors in microbiology and microbial technology from the University of Warwick, Coventry. 

BioNano Genomics will be at the European Human Genetics Conference 2013 presented by the European Society of Human Genetics (ESHG) taking place in Paris from June 8 to 11.  In addition, Pui-Yan Kwok , M.D., Ph.D., Henry Bachrach Distinguished Professor at the UCSF School of Medicine, will be giving a podium presentation on genome-wide structural variation analysis and de novo sequence assembly at ESHG on June 9th at 1:15 pm in the Grand Amphithéatre. 

About Irys

Irys makes it possible to routinely and accurately detect genomic structural variation and to finish genome assemblies. The fully automated Irys benchtop instrument uses the IrysChip to uncoil and confine long DNA molecules in proprietary Nanochannel Arrays™ where they are uniformly linearized in a highly parallel display for high-resolution, single-molecule imaging. Irys does not employ DNA fragmentation or amplification, which are typical with next-generation sequencing. The result is sequence information over extremely long "reads" ranging from hundreds of kilobases to a megabase, where the sample's valuable structural information is preserved. Irys makes it possible for researchers to directly observe structural variants including replications, deletions, translocations and inversions.

About BioNano Genomics

Headquartered in San Diego, BioNano Genomics is delivering an altogether better way of gaining a fully informed understanding of genomes. The Company's platform provides researchers and clinicians the most comprehensive, organized and actionable picture of a genome with unprecedented insights into how the individual components of genomes are ordered, arranged, and interact with each other. BioNano Genomics works with institutions in life science, translational research, molecular diagnostics and personalized medicine. The Company is supported by private investors and grant funding from genomics programs at federal agencies, including the NIH and NIST-ATP.

www.BioNanoGenomics.com

Notes: BioNano Genomics is a trademark of BioNano Genomics, Inc. Any other names of actual companies, organizations, entities, products or services may be the trademarks of their respective owners.


'/>"/>
SOURCE BioNano Genomics
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Mount Sinai Selects Exemplar LIMS for Genomics Core Facility
2. BGI hosts its 2nd International Conference on Genomics in the Americas
3. New supercomputer to aid genomics research
4. Nurses at forefront of genomics in healthcare
5. The 2013 International Conference on Genomics in Europe will take place in Ghent, Belgium
6. Big genomics data, big scientific impact: New challenges for further development of life science
7. Bridging the gap between genomics and education
8. Ontario Genomics Institute invests in validation of a novel protein interaction technology at U of T
9. New genomics study shows ancestry could help solve disease riddles
10. Physiological Genomics journal announces a major restructuring
11. 2 pioneering plant genomics efforts given a funding boost by National Science Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/1/2016)... Feb. 1, 2016  Today, the first day of ... plans to develop a first of its kind workplace ... IBM Watson. In the first application of ... IBM ), and Welltok will create a new ... with cognitive analytics, delivered on Welltok,s health optimization platform. ...
(Date:1/25/2016)...   Unisys Corporation (NYSE: UIS ) today announced ... International Airport, New York City , to help ... to enter the United States using passports ... pilot testing of the system at Dulles last year. The ... during January 2016. --> pilot testing of the ...
(Date:1/21/2016)... --> ... report "Emotion Detection and Recognition Market by Technology (Bio-Sensors, NLP, ... Voice Recognition and Others), Services, Application Areas, End ... published by MarketsandMarkets, the global Emotion Detection and ... Billion by 2020, at a CAGR of 31.9%, ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... 2016 - New FDA action date of ... FDA action date of July 22, 2016   ... 22, 2016   - Lifitegrast has ... indicated for the treatment of signs and symptoms of dry eye ... potential to be the only product approved in the U.S. in the past decade indicated ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... Digital Forensics Club, takes place February 5-6 at the University’s student center, ... and activities such as workshops and competitions for ample networking, learning and ...
(Date:2/4/2016)... Columbia and MENLO PARK, Calif. ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused ... announced that it will present at the 18 th ... February 8, 2016 at 10:00 a.m. EST in ... , DelMar,s president and CEO, will provide an update on ...
(Date:2/4/2016)... -- Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual property development ... property, today provided an update on the Company,s cases ... Texas and announcing that those ... Re-examination ("IPR") proceedings that VTech and Uniden filed ... on only certain claims of two of the patents ...
Breaking Biology Technology: